Evidence map›Paper›PMID 31260803›Full record

ArticleReproductive toxicology (Elmsford, N.Y.)2019

Developmental exposure to the endocrine disruptor tolylfluanid induces sex-specific later-life metabolic dysfunction.

Daniel Ruiz, Shane M Regnier, Andrew G Kirkley, Manami Hara, Fidel Haro, Hani Aldirawi, Michael P Dybala, Robert M Sargis

Open access · greenAbstract read
In one paragraph

Article in Reproductive toxicology (Elmsford, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Adipose Tissue and Endocrine-Disrupting Chemicals: Does Sex Matter?International journal of environmental research and public health · 2020
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Daniel RuizCommittee on Molecular Metabolism and Nutrition, Chicago, IL, United States; University of Chicago, Chicago, IL, United States.
Shane M RegnierCommittee on Molecular Metabolism and Nutrition, Chicago, IL, United States; Pritzker School of Medicine, Chicago, IL, United States; University of Chicago, Chicago, IL, United States.
Andrew G KirkleyCommittee on Molecular Pathogenesis and Molecular Medicine, Chicago, IL, United States; University of Chicago, Chicago, IL, United States.
Manami HaraSection of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Chicago, IL, United States; University of Chicago, Chicago, IL, United States.
Fidel HaroUniversity of Chicago, Chicago, IL, United States.
Hani AldirawiDepartment of Mathematics, Statistics, and Computer Science, University of Illinois at Chicago, Chicago, IL, United States.
Michael P DybalaSection of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Chicago, IL, United States.
Robert M SargisDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United States. Electronic address: rsargis@uic.edu.
University of Chicago · USUniversity of Illinois Chicago · US

Funding

TRANSGENIC COREP60DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI BELL, GRAEME I · 1985 to 2012
$25.5M
Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI Matthew J Brady · 2013 to 2026
$20.9M
Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)T32HD007009 · NICHD · UNIVERSITY OF CHICAGO · PI NANCY B SCHWARTZ · 1985 to 2026
$13.0M
University of Chicago Initiative for Maximizing Student Development (IMSD) - Renewal 01R25GM109439 · NIGMS · UNIVERSITY OF CHICAGO · PI SCHWARTZ, NANCY B · 2014 to 2023
$5.7M
Selenoproteins in Arsenic-Induced Metabolic DysfunctionR01ES028879 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SARGIS, ROBERT M · 2018 to 2022
$2.7M
Heterogeneity of the human pancreasR01DK117192 · NIDDK · UNIVERSITY OF CHICAGO · PI HARA, MANAMI · 2019 to 2023
$2.0M
Environmental Endocrine Disruption of Adipocyte MetabolismK08ES019176 · NIEHS · UNIVERSITY OF CHICAGO · PI SARGIS, ROBERT M · 2010 to 2014
$797k
Metabolic Impact of Fetal or Adult Exposure to Environmental Endocrine DisruptorsR21ES021354 · NIEHS · UNIVERSITY OF CHICAGO · PI SARGIS, ROBERT M · 2013 to 2014
$432k
NICHD NIH HHS T32 HD007009NIDDK NIH HHS P30 DK020595NIDDK NIH HHS P60 DK020595NIDDK NIH HHS R01 DK117192NIEHS NIH HHS K08 ES019176NIEHS NIH HHS P30 ES027792NIEHS NIH HHS R01 ES028879NIEHS NIH HHS R21 ES021354NIGMS NIH HHS R25 GM109439
6 · The paper itself

Abstract

Endocrine-disrupting chemicals (EDCs) are implicated in the developmental mis-programming of energy metabolism. This study examined the impact of combined gestational and lactational exposure to the fungicide tolylfluanid (TF) on metabolic physiology in adult offspring. C57BL/6 J dams received standard rodent chow or the same diet containing 67 mg/kg TF. Offspring growth and metabolism were assessed up to 22 weeks of age. TF-exposed offspring exhibited reduced weaning weight. Body weight among female offspring remained low throughout the study, while male offspring matched controls by 17 weeks of age. Female offspring exhibited reduced glucose tolerance, markedly enhanced systemic insulin sensitivity, reduced adiposity, and normal gluconeogenic capacity during adulthood. In contrast, male offspring exhibited impaired glucose tolerance with unchanged insulin sensitivity, no differences in adiposity, and increased gluconeogenic capacity. These data indicate that developmental exposure to TF induces sex-specific metabolic disruptions that recapitulate key aspects of other in utero growth restriction models.

Indexed as

AdiposityAnimalsEndocrine DisruptorsFemaleInsulin ResistanceMaternal ExposureMetabolic DiseasesMiceMice, Inbred C57BLPregnancyPrenatal Exposure Delayed EffectsReceptors, GlucocorticoidSex CharacteristicsSulfonamidesToluidinesEndocrine DisruptorsN-dichlorofluoromethylthio-N',N'-dimethyl-N-p-tolylsulfamideReceptors, GlucocorticoidSulfonamidesToluidinesAdiposeEndocrine disruptorGlucocorticoidGluconeogenesisGlucose toleranceInsulin sensitivityPerinatalSex differencesTolylfluanid

Identifiers

PMID31260803
PMCPMC6766412
OpenAlexW2953469708

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.